From: 11C-acetate PET/CT in pre-therapeutic lymph node staging in high-risk prostate cancer patients and its influence on disease management - a retrospective study
n
Mean
Range
Patients (n)
50
Age (years)
67
41 to 77
PSA (ng/ml)
37
2.7 to 168
Gleason score
8
6 to 10
Estimated risk of locoregional lymph node metastases (%)a
32
3.3 to 80.3